BASF is extending its offer period to acquire all of the issued and outstanding shares of Pronova BioPharma ASA, Lysaker, Norway, for NOK 12.50 per share in cash until January 18.
Besides being a solutions destination for personal care and pharmaceutical companies, BASF can now cater to food and dietary supplement customers as well.
BASF has announced its integration plans for Cognis. BASF expects to achieve an additional EBIT of €275 million (10.6% of Cognis’ 2009 net sales) through the integration. This consists of growth synergy targets to generate an additional EBIT of €135 million by 2015 and cost synergies of around €140 million which will be achieved by the end of 2013.